Baillie Gifford & CO Orchard Therapeutics PLC Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021
SELL
$3.86 - $5.07 $10.6 Million - $13.9 Million
-2,740,000 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$10.15 - $15.58 $18.4 Million - $28.3 Million
1,815,000 Added 196.22%
2,740,000 $37.7 Million
Q4 2018

Feb 14, 2019
BUY
$12.4 - $18.7 $11.5 Million - $17.3 Million
925,000 New
925,000 $14.6 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email